Zobrazeno 1 - 10
of 214
pro vyhledávání: '"Beth Harper"'
Publikováno v:
Clinical Pediatrics. 61:659-663
Autor:
Manoj K. Mittal, Joel S. Tieder, Kathryn Westphal, Erin Sullivan, Matt Hall, Risa Bochner, Adam Cohen, Jennifer Y. Colgan, Atima C. Delaney, Amy M. DeLaroche, Thomas Graf, Beth Harper, Ron L. Kaplan, Hannah C. Neubauer, Mark I. Neuman, Nirav Shastri, Victoria Wilkins, Allayne Stephans
Publikováno v:
Academic Emergency Medicine.
Characterizing Pain Points in Clinical Data Management and Assessing the Impact of Mid-Study Updates
Autor:
Kenneth A. Getz, Van C. Willis, Zachary Smith, Jane L. Snowdon, Rezzan Hekmat, Beth Harper, Dilhan Weeraratne, Robert DiCicco
Publikováno v:
Therapeutic Innovation & Regulatory Science
Ther Innov Regul Sci
Ther Innov Regul Sci
Background The causes, degree and disruptive nature of mid-study database updates and other pain points were evaluated to understand if and how the clinical data management function is managing rapid growth in data volume and diversity. Methods Tufts
Publikováno v:
Therapeutic Innovation & Regulatory Science. 55:272-281
Contending with a continuously expanding volume and variety of clinical data poses challenges and opportunities for the industry and clinical data management organizations. Tufts CSDD conducted an online survey aimed at further quantifying and unders
Autor:
Angela Doswell, James Anderst, Joel S. Tieder, Bruce E. Herman, Matt Hall, Victoria Wilkins, Miguel L. Knochel, Ron Kaplan, Adam Cohen, Amy M. DeLaroche, Beth Harper, Manoj K. Mittal, Nirav Shastri, Melanie Prusakowski, Henry T. Puls
Publikováno v:
Child Abuse & Neglect. 135:105952
A Brief Resolved Unexplained Event (BRUE) can be a sign of occult physical abuse.To identify rates of diagnostic testing able to detect physical abuse (head imaging, skeletal survey, and liver transaminases) at BRUE presentation. The secondary object
Autor:
DrugDev
Publikováno v:
Business Wire (English). 03/30/2015.
Publikováno v:
Therapeutic Innovation & Regulatory Science. 52:572-578
Site identification, site selection, and study start-up have become the focus of improvement by organizations conducting clinical trials.To examine and measure the process from site identification through site activation, Tufts Center for the Study o
Autor:
Zachary Smith, Kenneth A. Getz, Van C. Willis, Robert DiCicco, Rezzan Hekmat, Jane L. Snowdon, Beth Harper, Dilhan Weeraratne
Publikováno v:
Therapeutic Innovation & Regulatory Science. 55:1013-1013
Publikováno v:
Therapeutic innovationregulatory science. 54(1)
The Tufts Center for the Study of Drug Development conducted a study updating benchmarks on outsourcing model adoption and assessing oversight practices and experience.An online survey examining organizational use of clinical development outsourcing
Publikováno v:
Therapeutic innovationregulatory science. 53(1)
The volume and diversity of data collected to support each clinical study has increased dramatically in response to the rising scope and complexity of global drug development programs. The Tufts Center for the Study of Drug Development conducted an o